Lung Cancer Genomic Testing Market: Introduction
The Global Lung Cancer Genomic Testing Market has seen continuous development in the past couple of years and is anticipated to grow much further during 2020-2026. The exploration introduces a total evaluation of the Lung Cancer Genomic Testing market and contains Future patterns, Current Growth Factors, mindful sentiments, certainties, chronicled information, and factually bolstered and industry-approved market information.
The global lung cancer genomic testing market size was valued at USD 1.38 billion in 2021. It is expected to reach USD 3.01 billion by 2030, growing at a CAGR of 9% during the forecast (2022–2030).
Competitive Analysis
The report contains an in-depth analysis of the vendor's profile, including financial health, business units, key business priorities, SWOT, strategies, and views.
QIAGEN N.V. Agilent Technologies, Inc. Thermo Fisher Scientific, Inc. Quest Diagnostics Incorporated Laboratory Corporation of America Holdings CENTOGENE N.V. BGI CeGaT GmbH Illumina, Inc. Hoffmann-La Roche Ltd. Abbott Laboratories CD Genomics NeoGenomics Laboratories Admera Health OncoDNA OPKO Health, Inc. Invitae Corporation Veracyte, Inc.
The vendors have been identified based on the portfolio, geographical presence, marketing distribution channels, revenue generation, and significant RD investments.
Request Sample Report of Global Lung Cancer Genomic Testing Market @ https://straitsresearch.com/report/lung-cancer-genomic-testing-market/request-sample
Vendors across different verticals are planning for high investments in this market, and as a result, the market is expected to grow at an impressive rate in the upcoming years. The key players are adopting various organic and inorganic growth strategies such as mergers acquisitions, collaboration partnerships, joint ventures, and a few other strategies to be in a strong position in the global market.
Market Segmentation Analysis
The report provides a wide-ranging evaluation of the market, providing in-depth qualitative insights, historical data, and supportable projections along with the assumptions about the Lung Cancer Genomic Testing market size. The projections featured in the report have been derived using proven research methodologies and assumptions based on the vendor's portfolio, blogs, white papers, and vendor presentations. Thus, the research report represents every side of the Lung Cancer Genomic Testing market and is segmented on the basis of regional markets, offerings, applications, and end-users.
By Type Products Services By Technology Polymerase Chain Reaction (PCR) Next-Generation Sequencing (NGS) Fluorescence in Situ Hybridization By Sample Type Tissue biopsy Liquid biopsy By Panel Type Multi-Gene panels Single-Gene panels By End-User Research organizations Hospitals/Clinics Diagnostic Laboratories
Regional Analysis
North America held the largest Lung Cancer Genomic Testing market share in 2018 and is expected to dominate the market during the forecast period. The market will experience a steep rise in the following regions covered- North America, Europe, Asia Pacific, Latin America, and the Middle East Africa.
Benefits
Lung Cancer Genomic Testing Industry companies to ensure business continuity with powerful protection by constantly checking the report and representing attractive growth opportunities for the companies. Lung Cancer Genomic Testing handles all the needs of the operators by allowing them to improve their services and concentrate on their core business. Lung Cancer Genomic Testing Market Research aims to increase business agility and reduce operational and capital expenditure with improved technology rollouts and capacity planning. The report discusses service types and regions related to this Lung Cancer Genomic Testing market. Further, the report provides details about the major challenges affecting the market growth.
Buy Now: https://straitsresearch.com/buy-now/lung-cancer-genomic-testing-market
Other features of the report:
- Provides a thorough analysis of the key strategies with a focus on the corporate structure, RD methods, localization strategies, production capabilities, sales, and performance in various companies.
- Provides valuable insights into the product portfolio, including product planning, development, and positioning.
- Analyses the role of key Lung Cancer Genomic Testing market players and their partnerships along with mergers and acquisitions.
Thanks for reading this article; you can also get individual chapter-wise sections or region-wise report versions like North America, Europe, or Asia.
Trending Report:
https://www.openpr.com/news/2438569/non-liquid-coating-market-size-worth-usd-12-billion-globally
https://www.openpr.com/news/2435467/global-aluminum-beverage-cans-market-expected-to-reach-highest
About Us:
StraitsResearch.com is a leading research and intelligence organization, specializing in research, analytics, and advisory services along with providing business insights research reports.
Contact Us:
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY, USA, 10022
Tel: +1 6464807505, +44 203 318 2846
